Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 4 Interventional

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

ClinicalTrials.gov ID: NCT03988114

Public ClinicalTrials.gov record NCT03988114. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single-Arm, Global, Phase 4 Study of Abemaciclib, a CDK 4 & 6 Inhibitor, in Combination With Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) in Participants With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Advanced Breast Cancer With Poor Prognostic Factors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The reason for this study is to see if the drug abemaciclib in combination with nonsteroidal aromatase inhibitors (anastrozole or letrozole) is effective in participants with Hormone Receptor Positive (HR+), Human Epidermal Growth Factor Receptor 2 Negative (HER2-) advanced breast cancer that have certain disease characteristics.

Study identification

NCT ID
NCT03988114
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 4
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 16, 2019 (Estimated)
Primary completion
Mar 23, 2022 (Estimated)
Completion
Mar 23, 2023 (Estimated)
Last update posted
Sep 6, 2019

2019 – 2023

United States locations

U.S. sites
70
U.S. states
21
U.S. cities
63
Facility City State ZIP Site status
Southern Cancer Center, P.C. Daphne Alabama 36526 —
Arizona Oncology Associates, P.C. Tempe Arizona 85284 —
Compassionate Cancer Care Medical Group Inc Fountain Valley California 92708 —
California Cancer Associates Research and Excellence (cCARE) Fresno California 93720 —
Beaver Medical Group Highland California 92346 —
Pacific Cancer Care Monterey California 93940 —
St. Joseph Hospital Orange California 92868 —
Comprehensive Cancer Centers of the Desert Palm Springs California 92262 —
California Cancer Associates in Research and Excellence San Marcos California 92069 —
Cancer Center of Santa Barbara with Sansum Clinic Santa Barbara California 93105 —
UCLA Medical Center Torrance California 90502 —
Memorial Hospital Colorado Springs Colorado 80909 —
Rocky Mountain Cancer Center Lone Tree Colorado 80124 —
Medical Oncology Hematology Consultants, PA Newark Delaware 19713 —
BayCare Medical Group Clearwater Florida 33756 —
Florida Cancer Specialists Fort Myers Florida 33901 —
Woodlands Medical Specialists Pensacola Florida 32503 —
Cancer Specialists of North Florida -St Augustine Saint Augustine Florida 32086 —
Florida Cancer Specialists St. Petersburg Florida 33705 —
Florida Cancer Specialists Tallahassee Florida 32308 —
Florida Cancer Specialists West Palm Beach Florida 33401 —
Cleveland Clinic of Florida Weston Florida 33331 —
Summit Cancer Care Savannah Georgia 31404 —
Ingalls Memorial Hospital Harvey Illinois 60426 —
Illinois Cancer Specialists-Niles Niles Illinois 60714 —
Community Health Network Indianapolis Indiana 46219 —
Central Maine Medical Center Lewiston Maine 04240 —
York Hospital York Village Maine 03909 —
HCA Midwest Kansas City Missouri 64132 —
Oncology Hematology West Omaha Nebraska 68130 —
Comprehensive Cancer Centers of Nevada Henderson Nevada 89052 —
Valley Health System Paramus New Jersey 07652 —
Broome Oncology LLC Johnson City New York 13790 —
Abington Hematology Oncology Associates Horsham Pennsylvania 19044 —
Charleston Hematology Oncology Associates Charleston South Carolina 29414 —
Sarah Cannon Research Institute SCRI Nashville Tennessee 37203 —
Tennessee Oncology PLLC Nashville Tennessee 37203 —
Texas Oncology - Abilene Abilene Texas 79606 —
Texas Oncology - Amarillo Amarillo Texas 79106 —
Texas Oncology-Arlington South Arlington Texas 76014 —
Texas Oncology Cancer Center Austin Texas 78731 —
Texas Oncology - Bedford Bedford Texas 76022 —
Texas Oncology P.A. Dallas Texas 75203 —
Texas Oncology - Medical City Dallas Dallas Texas 75230 —
Texas Oncology - Dallas Presbyterian Hospital Dallas Texas 75231 —
Texas Oncology-Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 —
Texas Oncology - Marnie McFadden Ward Cancer Center Dallas Texas 77702 —
Texas Oncology P.A. El Paso Texas 79902 —
Texas Oncology Flower Mound Flower Mound Texas 75028 —
The Center for Cancer and Blood Disorders Fort Worth Texas 76104 —
Texas Oncology-Memorial City Houston Texas 77024 —
Renovatio Clinical Houston Texas 77056 —
Texas Oncology - McAllen McAllen Texas 78503 —
Texas Oncology-McKinney McKinney Texas 75771 —
Texas Oncology- Mesquite Mesquite Texas 75150 —
Texas Oncology - Midland Allison Cancer Center Midland Texas 79701 —
Texas Oncology - Paris Paris Texas 75460 —
Texas Oncology-Plano East Plano Texas 75075 —
Texas Oncology-Plano West Plano Texas 75093 —
Texas Oncology - San Antonio Medical Center San Antonio Texas 78217 —
Texas Oncology-Sherman Sherman Texas 75090-0504 —
US Oncology The Woodlands Texas 77380 —
Tyler Cancer Center Tyler Texas 75702 —
Texas Oncology-Deke Slayton Cancer Center Webster Texas 77598-4219 —
Texas Oncology-Wichital Falls Texoma Cancer Center Wichita Falls Texas 76310 —
Intermountain Medical Center St. George Utah 84790 —
Hematology Oncology Associates of Fredericksburg Inc. Fredericksburg Virginia 22408 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Oncology and Hematology Associates of Southwest Virginia Inc Salem Virginia 24153 —
Shenandoah Oncology, P.C. Winchester Virginia 22601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03988114, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 6, 2019 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03988114 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →